| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/24/2013 | US8614064 Methods of diagnosing atherosclerosis by measuring ApoCI |
| 12/24/2013 | US8614063 Methods for screening for compounds for treating cancer |
| 12/24/2013 | US8614062 RNA-based system and method to differentiate seafood |
| 12/24/2013 | US8614061 Combination of fluorescent dyes for the detection of nucleic acids |
| 12/24/2013 | US8614060 Methods and compositions for predicting drug responses |
| 12/24/2013 | US8614059 Purification and concentration of proteins and DNA from a complex sample using isotachophoresis and a device to perform the purification |
| 12/24/2013 | US8614058 Molecular prognostic signature for predicting breast cancer metastasis, and uses thereof |
| 12/24/2013 | US8614057 Methods for collecting and detecting oligonucleotides |
| 12/24/2013 | US8614056 Microfluidic method for measurement or detection involving cells or biomolecules |
| 12/24/2013 | US8614055 Prognosis and treatment of breast cancer |
| 12/24/2013 | US8613936 Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements |
| 12/24/2013 | US8613918 Method for treating pervasive development disorders |
| 12/24/2013 | US8613837 Detection and quantification of nucleic acid to assess microbial biomass in paper defects and machine felts |
| 12/24/2013 | DE112012000821T5 Zusammensetzung und Verfahren zum Diagnostizieren von Eierstockkrebs Composition and method for diagnosing ovarian cancer |
| 12/24/2013 | DE102013106380A1 Liquid-based sensor device, useful for detecting the presence of analyte e.g. bacteria cell, comprises substrates, liquid crystal layer, and phospholipid layer, reaction layer, electrodes, and insulating layer and/or alignment layer |
| 12/24/2013 | DE102012210598A1 Verfahren und Anordnung zur Detektion von Zellen in einer Zellsuspension Method and arrangement for the detection of cells in a cell suspension |
| 12/24/2013 | CA2790915C Method, tools and kits for the detection of members of the streptococcus genus |
| 12/24/2013 | CA2707684C Novel exoenzyme toxin of aeromonas salmonicida, and uses therefor |
| 12/24/2013 | CA2682108C Methods for generating high titer helper-free preparations of recombinant aav vectors |
| 12/24/2013 | CA2609558C Identification of compounds modifying a cellular response |
| 12/24/2013 | CA2526790C Method for screening inhibitors of the gamma-secretase |
| 12/24/2013 | CA2487915C Allergen from mugwort pollen |
| 12/24/2013 | CA2485988C Methods of modulating tubulin deacetylase activity |
| 12/24/2013 | CA2481323C Biological substance-immobilized gel and microarray using the same |
| 12/24/2013 | CA2397199C Nogo receptor-mediated blockade of axonal growth |
| 12/24/2013 | CA2302484C Cultures of human cns neural stem cells |
| 12/19/2013 | WO2013188872A1 High throughput sequencing of multiple transcripts of a single cell |
| 12/19/2013 | WO2013188851A1 Ex vivo expansion of myogenic stem cells by notch activation |
| 12/19/2013 | WO2013188846A1 Methods of detecting diseases or conditions |
| 12/19/2013 | WO2013188841A1 Chip set-up and high-accuracy nucleic acid sequencing |
| 12/19/2013 | WO2013188840A1 Compositions and methods for sensitive mutation detection in nucleic acid molecules |
| 12/19/2013 | WO2013188839A1 Novel compositions, methods and kits for real time polymerase chain reaction (pcr) |
| 12/19/2013 | WO2013188832A1 Methods for microvesicle isolation and selective removal |
| 12/19/2013 | WO2013188831A1 Uniquely tagged rearranged adaptive immune receptor genes in a complex gene set |
| 12/19/2013 | WO2013188823A2 Cancer prognostic assays |
| 12/19/2013 | WO2013188787A1 INHIBITORS OF MICRORNAs THAT REGULATE PRODUCTION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AS THERAPEUTICS AND USES THEREOF |
| 12/19/2013 | WO2013188772A1 Methods for antibody and cell therapeutic discovery |
| 12/19/2013 | WO2013188748A1 Technology for cell transdifferentiation |
| 12/19/2013 | WO2013188638A2 Endoribonucleases and methods of use thereof |
| 12/19/2013 | WO2013188612A1 Genetic loci associated with soybean cyst nematode resistance and methods of use |
| 12/19/2013 | WO2013188605A2 Predictive markers for cancer and metabolic syndrome |
| 12/19/2013 | WO2013188600A1 Copy number aberration driven endocrine response gene signature |
| 12/19/2013 | WO2013188582A1 Kinetic exclusion amplification of nucleic acid libraries |
| 12/19/2013 | WO2013188578A1 Efficient, expansive, user-defined dna mutagenesis |
| 12/19/2013 | WO2013188576A2 Complex rna composition of bodily fluids |
| 12/19/2013 | WO2013188501A1 Genetic loci associated with resistance of soybean to cyst nematode and methods of use |
| 12/19/2013 | WO2013188491A1 Polynucleotide probe design |
| 12/19/2013 | WO2013188471A2 Method of sequence determination using sequence tags |
| 12/19/2013 | WO2013188436A1 System and method for detecting cancer |
| 12/19/2013 | WO2013188406A1 Assays of chromatin mediated transcription modulation and compositions used therein |
| 12/19/2013 | WO2013188333A1 Biomarkers related to nephrotoxicity and methods using the same |
| 12/19/2013 | WO2013188267A2 Methods and compositions for determination of vector backbone in a nucleic acid sample |
| 12/19/2013 | WO2013188102A1 Methods and kits for detecting a xerophilic microorganism or an osmophilic microorganism |
| 12/19/2013 | WO2013187973A1 Devices and methods for determining sensitivity to radiation |
| 12/19/2013 | WO2013187958A1 Methods and compositions for detection of legionella |
| 12/19/2013 | WO2013187910A1 Self-cleaning lens |
| 12/19/2013 | WO2013187628A1 Detection of target nucleic acid sequence by pto cleavage and extension-dependent transcription |
| 12/19/2013 | WO2013187468A1 Interaction prediction device, interaction prediction method, and program |
| 12/19/2013 | WO2013187302A1 Test paper |
| 12/19/2013 | WO2013186946A1 Method for selecting pluripotent stem cell |
| 12/19/2013 | WO2013186857A1 Aptamer to fgf2 and use thereof |
| 12/19/2013 | WO2013186754A2 Method for detecting and identifying enterohemorrhagic escherichia coli |
| 12/19/2013 | WO2013186718A1 Method for quantifying different viral forms of the dna of the hiv virus |
| 12/19/2013 | WO2013186639A2 Methylation biomarkers for breast cancer |
| 12/19/2013 | WO2013186633A1 Methylation biomarkers for prostate cancer |
| 12/19/2013 | WO2013186591A1 Method for culturing phytoplasma |
| 12/19/2013 | WO2013186541A1 Biomarker for determining the suitability of anti -tumour necrosis factor (anti-tnf) therapy in the treatment of autoimmune diseases |
| 12/19/2013 | WO2013186422A1 Method for screening and/or evaluating the efficacy of medicaments for the treatment of mitochondrial diseases and melas syndrome |
| 12/19/2013 | WO2013186418A1 Marker for determining the therapeutic potential of mesenchymal stem cells, an inhibitor of the marker for therapeutic use and stem cells with low expression of the marker for therapeutic use |
| 12/19/2013 | WO2013186359A1 Analysis method on the basis of an array |
| 12/19/2013 | WO2013186352A1 Assay and method for predicting therapeutic efficacy of immunoglobulin therapy in individual patients with relapsing remitting multiple sclerosis (rr-ms) |
| 12/19/2013 | WO2013186253A1 Catalase in growth media |
| 12/19/2013 | WO2013185896A1 Device for standardising the in-vitro synergy testing of two antibiotics through the method crossing the gradient strips |
| 12/19/2013 | WO2013185779A2 Biomarkers for prostate cancer |
| 12/19/2013 | WO2013185771A1 Assays for detecting glucosidase activity |
| 12/19/2013 | WO2013185239A1 Transgenic mouse models for mc4r |
| 12/19/2013 | WO2013154304A3 Method for preparing a nucleic acid with high precision used in detecting a nucleic acid with a nucleic acid polymerase |
| 12/19/2013 | WO2013136059A3 Biomarker, uses thereof and therapy |
| 12/19/2013 | WO2013114406A3 Primer for amplifying farnesyl pyrophosphate synthase from mango |
| 12/19/2013 | WO2013093324A3 Method for the diagnosis or prognosis, in vitro, of prostate cancer |
| 12/19/2013 | WO2012175183A8 Determination of direct thrombin inhibitors in fluids like serum or urine |
| 12/19/2013 | US20130340112 Plant genome sequence and uses thereof |
| 12/19/2013 | US20130340101 Novel Homeobox Gene |
| 12/19/2013 | US20130338214 Method for suppressing receptor tyrosine kinase-mediated pro-survival signaling in cancer cell |
| 12/19/2013 | US20130338212 Genetic Changes In ATM And ATR/Chek1 As Prognostic Indicators In Cancer |
| 12/19/2013 | US20130338192 Method for augmenting the effects of serotonin reuptake inhibitors |
| 12/19/2013 | US20130338188 Pharmaceutical compositions and administrations thereof |
| 12/19/2013 | US20130338102 Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions |
| 12/19/2013 | US20130338041 Nucleic acid analysis device and nucleic acid analyzer |
| 12/19/2013 | US20130338040 LKB1 Levels and Brain Metastasis from Non-Small-Cell Lung Cancer (NSCLC) |
| 12/19/2013 | US20130338037 Detection of staphylococcus aureus and identification of methicillin-resistant staphylococcus aureus |
| 12/19/2013 | US20130338036 Detection of staphylococcus aureus and identification of methicillin-resistant staphylococcus aureus |
| 12/19/2013 | US20130338035 MHC Genes and Risk of Graft Versus Host Disease |
| 12/19/2013 | US20130338034 Metabolic diseases-related odorant receptor genes and use thereof |
| 12/19/2013 | US20130338032 Assay for determining epigenetic profiles of markers of fragile x alleles |
| 12/19/2013 | US20130338027 Predictive Markers For Cancer and Metabolic Syndrome |
| 12/19/2013 | US20130338026 Prognostic Marker for Endometrial Carcinoma |
| 12/19/2013 | US20130338025 Use of gene expression profiling to predict survival in cancer patient |
| 12/19/2013 | US20130338024 Class ii human histone deacetylases, and uses related thereto |
| 12/19/2013 | US20130338023 Bach2 repression in cells |